Cargando…
Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring
BACKGROUND: Antiarrhythmic drugs are often used in the management of patients with atrial fibrillation (AF). Sotalol is conventionally initiated in the inpatient setting for monitoring efficacy and adverse effects, including QTc interval prolongation and torsades de pointes (TdP) proarrhythmia. OBJE...
Autores principales: | Mascarenhas, Daniel A. N., Mudumbi, Praveen C., Kantharia, Bharat K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295005/ https://www.ncbi.nlm.nih.gov/pubmed/34291437 http://dx.doi.org/10.1007/s40256-021-00493-7 |
Ejemplares similares
-
Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown
por: Mascarenhas, Daniel A. N., et al.
Publicado: (2021) -
Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
por: Lenhoff, H, et al.
Publicado: (2023) -
Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load
por: Von Bergen, Nicholas H., et al.
Publicado: (2019) -
Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
por: Lenhoff, Hanna, et al.
Publicado: (2021) -
Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation
por: Varela, Daniel L., et al.
Publicado: (2022)